http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111603468-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0004
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
filingDate 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-111603468-B
titleOfInvention A kind of berberine composition and its preparation method and application
abstract The present invention is applicable to the technical field of medicine, and provides a berberine composition, a preparation method and application thereof. The berberine composition comprises berberine, hydrophilic auxiliary materials, microcrystalline cellulose, lactose, and a binder. , disintegrant, glidant. Wherein, the hydrophilic auxiliary material is mannitol and/or sorbitol; the binder is polyvinylpyrrolidone and/or hydroxypropyl methylcellulose; the disintegrant is crospovidone or croscarmellose sodium ; Glidants are talc and/or silicon dioxide. In the present invention, the berberine is dispersed by using a hydrophilic auxiliary material, and under the action of a small amount of water-insoluble auxiliary materials such as microcrystalline cellulose, it is beneficial to granulation and disintegration of the particles, so that the medicine is completely disintegrated in a short time. And the rapid dissolution will not bring about the problem of the uniformity of the concentration of the sitz bath medicinal solution, and does not require stirring, which improves the convenience of use.
priorityDate 2020-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019024949-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490943
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527835
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426260389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453357071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82170
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2353
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24832095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483315
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917

Total number of triples: 47.